Acetylation modification in malignant progression and therapeutic resistance of gliomas

Read full text Summarise with VIRAT
Authors: Jiayi Zhang, Mengying Wang, Hong Wang, Xuemei Jiang, Hanyan Zou
Cited by: 0
References: 267

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Gliomas are the most common and aggressive primary malignant tumors of the central nervous system, characterized by diffuse infiltration, rapid proliferation and dismal prognosis. Despite advances in multimodal treatments, including surgical resection, radiotherapy and targeted therapies, clinical outcomes remain unsatisfactory owing to the inevitable development of therapeutic resistance. Protein acetylation, a key post-translational modification dynamically regulated by lysine acetyltransferases and deacetylases, plays a central role in governing chromatin organization, transcriptional regulation, protein stability and signal transduction. Increasing evidence indicates that aberrant acetylation critically contributes to glioma malignant progression and treatment resistance by modulating essential cellular processes, including proliferation, apoptosis, invasion, metabolic reprogramming, DNA damage repair, immune evasion and cancer stemness. This review systematically summarizes recent advances in understanding the roles of both histone and non-histone acetylation in glioma biology, with particular emphasis on their involvement in resistance to chemotherapy and radiotherapy. Collectively, this review underscores acetylation as a pivotal epigenetic mechanism driving glioma aggressiveness and therapeutic resistance and provides mechanistic insights and a conceptual framework for the development of more effective and precise therapeutic strategies.

Fields of Study & Subjects

Glioma Diagnosis and Treatment Epigenetics and DNA Methylation Cancer Hypoxia and Metabolism

Publication details

Journal / source
Frontiers in Cell and Developmental Biology
Volume
14
Pages
1808361–1808361
Publication date
25 March 2026
Language
EN